Cedar Cove Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Sell
661
-22
-3% -$22.5K 0.37% 43
2026
Q1
$628K Buy
683
+370
+118% +$375K 0.33% 47
2025
Q4
$336K Buy
+313
New +$299K 0.18% 70

Other funds holding LLY

Cedar Cove Wealth Partners's LLY Position: Q2 2026 in Review

Cedar Cove Wealth Partners reduced its Eli Lilly (LLY) stake by 3.2% in Q2 2026, selling an estimated $22.5K and leaving 661 shares worth $792K. The position accounts for 0.37% of the portfolio, ranked #43.

Cedar Cove Wealth Partners first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 1,753 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cedar Cove Wealth Partners held 661 shares of Eli Lilly worth $792K as of Q2 2026.
  • Cedar Cove Wealth Partners sold 22 Eli Lilly shares in Q2 2026, an estimated $22.5K.
  • Eli Lilly made up 0.37% of Cedar Cove Wealth Partners's portfolio in Q2 2026, its #43 holding.
  • Cedar Cove Wealth Partners first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 1,753 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cedar Cove Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.